Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2008
11/27/2008US20080293687 Benzamide Compounds
11/27/2008US20080293686 Semi-solid systems containing azetidine derivatives
11/27/2008US20080293685 Spiro and other derivatives of diamondoids possessing therapeutic activity in the treatment of viral disorders
11/27/2008US20080293684 Heterocyclic Acetophenone Potentiators of Metabotropic Glutamate Receptors
11/27/2008US20080293683 Hormone Replacement Therapy
11/27/2008US20080293682 Novel Betulinic Acid Derivatives
11/27/2008US20080293681 Sprayable pharmaceutical compositions comprising a vitamin d derivative and an oily phase
11/27/2008US20080293680 Substituted Ethane-1,2-Diamines for the Treatment of Alzheimer's Disease II
11/27/2008US20080293679 Use of carotenoids and/or carotenoid derivatives/analogs for reduction/inhibition of certain negative effects of COX inhibitors
11/27/2008US20080293678 Organic Nitric Oxide Donor Salts of Angiotensin Converting Enzyme Inhibitors, Compositions and Methods of Use
11/27/2008US20080293677 Use of Alternating Amine and Non-Amine Bisphosphonate Combinations For Treating Osteoporosis
11/27/2008US20080293675 Antibiotics containing borinic acid complexes and methods of use
11/27/2008US20080293673 N-acetyglucosamine derivatives and use thereof
11/27/2008US20080293672 Lipid conjugates in the treatment of disease
11/27/2008US20080293671 Combination of Polychitosamine and Fibrate for the Prevention and Treatment of Hyperlipidemia
11/27/2008US20080293670 Edible tremella polysaccharide for prevention and/or improvement of intestinal disorder
11/27/2008US20080293669 Composition Containing Beta-Glucan, Method of Producing the Same and Foods, Drinks or Skin Moisturizers Containing the Composition
11/27/2008US20080293668 [5-carboxamido or 5-fluoro]-[2',3'-unsaturated or 3'-modified]-pyrimidine nucleosides
11/27/2008US20080293667 Lipid analogs for combating tumors
11/27/2008US20080293666 Antibacterial Agents
11/27/2008US20080293665 Purine Nucleotide Derivatives
11/27/2008US20080293664 Non-nucleoside reverse transcriptase inhibitors
11/27/2008US20080293663 Cellular genes regulated by hiv-1 infection and methods of use thereof
11/27/2008US20080293662 RNAi MODULATION OF THE BCR-ABL FUSION GENE AND USES THEREOF
11/27/2008US20080293661 Method for treating chronic lymphoid leukemia
11/27/2008US20080293660 Chemically-defined non-polymeric valency platform molecules and conjugates thereof
11/27/2008US20080293659 FC gamma RIIA-specific nucleic acid interference
11/27/2008US20080293658 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells
11/27/2008US20080293657 Modulation of the expression of stat-1-dependent genes
11/27/2008US20080293656 Processing nucleic acid
11/27/2008US20080293655 Novel tandem siRNAS
11/27/2008US20080293654 Therapeutic methods using Smads
11/27/2008US20080293653 Method of treating autoimmune diseases
11/27/2008US20080293652 Combination of Ad-P53 and Chemotherapy for the Treatment of Tumours
11/27/2008US20080293651 Cytosine nucleoside analogs and isoflavones and uses thereof
11/27/2008US20080293650 Fused Heterocyclic Compounds and Use Thereof
11/27/2008US20080293649 Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents
11/27/2008US20080293648 Compositions and Methods for Cancer Treatment
11/27/2008US20080293647 Combined Use Of Vitamin D Derivatives And Anti-Proliferative Agents For Treating Bladder Cancer
11/27/2008US20080293646 Macrolides
11/27/2008US20080293644 Guava extract
11/27/2008US20080293643 Crystalline Form I of 3,4'5-Trihydroxy-Stilbene-3-B-D Glucoside
11/27/2008US20080293642 C-Glycosylisoflavones Having Alkylaminoalkoxyl Substituent, Preparation and Use of the Same
11/27/2008US20080293631 Treatment for Autoimmune and Inflammatory Conditions
11/27/2008US20080293622 Methods of inducing ovulation
11/27/2008US20080293621 Methods for Prolonging Feline Life
11/27/2008US20080293619 Compositions and methods for treating malaria with cupredoxin and cytochrome
11/27/2008US20080293618 Cyclopropyl-fused pyrrolidine derivatives as dipeptidyl peptidase iv inhibitors
11/27/2008US20080293573 Use as pesticide, microbiocide, or herbicide
11/27/2008US20080293137 Compounds that abrogate dna damage induced cell cycle g2 checkpoint and/or augment anti-cancer activity of dna-damaging treatments
11/27/2008US20080293116 Ovary-specific genes and proteins
11/27/2008US20080293034 Organ arrest, protection, preservation and recovery
11/27/2008US20080292872 Substrate with a photocatalytic coating
11/27/2008US20080292736 Bioavailability enhancing activity of carum carvi extracts and fractions thereof
11/27/2008US20080292733 Antioxidant and Fe2+ Chelating Properties of Herbal Extracts
11/27/2008US20080292729 Stabilized Chlorite Solutions in Combination with Fluoropyrimidines for Cancer Treatment
11/27/2008US20080292726 Ophthalmic gallium compositions and methods of their use
11/27/2008US20080292724 Composition for improving membrane composition and functioning cells
11/27/2008US20080292714 Bone targeting of degradable drug filled nanoparticles
11/27/2008US20080292713 Respirable Powders
11/27/2008US20080292710 Liquid Dosage Forms Of Acid Labile Drugs
11/27/2008US20080292709 Kits for dhea and dhea-sulfate for the treatment of chronic obstructive pulmonary disease
11/27/2008US20080292707 Pharmaceutical Compositions of Adsorbates of Amorphous Drug
11/27/2008US20080292703 Antitumoral Bioconjugates of Hyaluronic Acid or Its Derivatives Obtained by Indirect Chemical Conjugation, and Their Use in the Pharmaceutical Field
11/27/2008US20080292702 Solid Dispersion Comprising An Active Ingredient Having A Low Melting Point And Tablet For Oral Administration Comprising Same
11/27/2008US20080292701 Lansoprazole dosage forms; fast disintegration in the oral cavity even without water
11/27/2008US20080292699 Solid pharmaceutical dosage unit for alleviating symptoms of rhinorrhea
11/27/2008US20080292698 Pharmaceutical compositions of isolated orthorhombic crystalline 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid and methods of use
11/27/2008US20080292697 Direct compression polymer tablet core
11/27/2008US20080292696 Enteric Sustained-Release Tablet Comprising Paroxetine
11/27/2008US20080292695 Carvedilol forms, compositions, and methods of preparation thereof
11/27/2008US20080292694 Opioid agonist/antagonist combinations
11/27/2008US20080292688 Liposome and preparation method of the same
11/27/2008US20080292687 Methods of Treating Cancer and Other Conditions or Disease States Using Lfmau and Ldt
11/27/2008US20080292685 Transdermal Patch Containing Isosorbide Dinitrate and Bisoprolol
11/27/2008US20080292683 Film shreds and delivery system incorporating same
11/27/2008US20080292681 Use of Dha, Epa or Dha-Derived Epa for Treating a Pathology Associated with Cellular Oxidative Damage
11/27/2008US20080292670 Adhesive and plaster
11/27/2008US20080292668 Water-Free Cosmetic Preparation
11/27/2008US20080292666 Preparation for Preventing or Treating Calcium Deficiency Conditions In Mammals
11/27/2008US20080292664 Hydrogels and Hyaluronic Acid and Alpha, Beta-Polyaspartyl-Hydrazide and Their Biomedical and Pharmaceutical Uses
11/27/2008US20080292654 Human Bocavirus and Methods of Diagnosis and Treatment
11/27/2008US20080292648 Synthetic agonists of tlr9
11/27/2008US20080292634 Nontypable Haemophilus Infuenzae Virulence Factors
11/27/2008US20080292631 Treatment with anti-vegf antibodies
11/27/2008US20080292630 Treatment with anti-vegf antibodies
11/27/2008US20080292628 Chimeric Protein
11/27/2008US20080292626 Kinesin inhibitors
11/27/2008US20080292624 Method of detecting and treating tuberous sclerosis complex associated disorders
11/27/2008US20080292619 Pharmaceutical Composition Containing Meltrin Antagonist
11/27/2008US20080292618 Intranuclear protein transduction through a nucleoside salvage pathway
11/27/2008US20080292617 Antibody against a peptide derived from human mutant lamin a protein and uses thereof
11/27/2008US20080292616 Topical Formulations of Histone Deacetylase Inhibitors and Methods Using the Same
11/27/2008US20080292615 Diagnosis and treatment of disease
11/27/2008US20080292614 DNA sequences for human angiogenesis genes
11/27/2008US20080292608 Compounds and Compositions as Ppar Modulators
11/27/2008US20080292606 Pharmaceutical Oral Dosage Form Comprising a Non-Steroidal Anti-Inflammatory Drug, and Having Good Palatability
11/27/2008US20080292602 T Cell Receptors Which Specifically Bind to Vygfvracl-Hla-A24
11/27/2008US20080292596 Edible mushroom-producing fungi; for producing reduced, methylated, biologically active forms of folate such as 5-methyltetrahydrofolate (5-MTHF) in a form that is easily ingested and absorbed in the intestines of a human
11/27/2008US20080292591 localized foci of model tumor cells highly correlated to actual clinical tumor cells; genetic engineering; drug screening
1 ... 2977 2978 2979 2980 2981 2982 2983 2984 2985 2986 2987 2988 2989 2990 2991 2992 2993 2994 2995 2996 2997 ... 7860